These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 15238112

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss.
    Obayashi S, Ozaki Y, Sugi T, Kitaori T, Katano K, Suzuki S, Sugiura-Ogasawara M.
    J Reprod Immunol; 2010 Jun; 85(2):186-92. PubMed ID: 20462639
    [Abstract] [Full Text] [Related]

  • 3. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases.
    Berard M, Chantome R, Marcelli A, Boffa MC.
    J Rheumatol; 1996 Aug; 23(8):1369-74. PubMed ID: 8856615
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses.
    Sugi T, Katsunuma J, Izumi S, McIntyre JA, Makino T.
    Fertil Steril; 1999 Jun; 71(6):1060-5. PubMed ID: 10360910
    [Abstract] [Full Text] [Related]

  • 5. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss.
    Kumar KS, Jyothy A, Prakash MS, Rani HS, Reddy PP.
    J Postgrad Med; 2002 Jun; 48(1):5-10. PubMed ID: 12082318
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.
    Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC, Almawi WY, Mahjoub T.
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr 01; 119(2):164-70. PubMed ID: 15808373
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC.
    Thromb Haemost; 2007 Jun 01; 97(6):949-54. PubMed ID: 17549297
    [Abstract] [Full Text] [Related]

  • 9. Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions.
    Matzner W, Chong P, Xu G, Ching W.
    J Reprod Med; 1994 Jan 01; 39(1):27-30. PubMed ID: 8169912
    [Abstract] [Full Text] [Related]

  • 10. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
    Gris JC, Quéré I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert AM, Ripart-Neveu S, Hoffet M, Tailland ML, Rousseau O, Monpeyroux F, Dauzat M, Sampol J, Daures JP, Berlan J, Marès P.
    Thromb Haemost; 2000 Aug 01; 84(2):228-36. PubMed ID: 10959694
    [Abstract] [Full Text] [Related]

  • 11. Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss.
    Tebo AE, Jaskowski TD, Hill HR, Branch DW.
    Clin Exp Immunol; 2008 Dec 01; 154(3):332-8. PubMed ID: 18826497
    [Abstract] [Full Text] [Related]

  • 12. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.
    Lee RM, Branch DW, Silver RM.
    Am J Obstet Gynecol; 2001 Sep 01; 185(3):748-53. PubMed ID: 11568809
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic performance of phospholipid-specific assays for the evaluation of antiphospholipid syndrome.
    Tebo AE, Jaskowski TD, Phansalkar AR, Litwin CM, Branch DW, Hill HR.
    Am J Clin Pathol; 2008 Jun 01; 129(6):870-5. PubMed ID: 18480002
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome".
    Sanmarco M.
    Autoimmun Rev; 2009 Dec 01; 9(2):90-2. PubMed ID: 19306951
    [Abstract] [Full Text] [Related]

  • 15. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
    Boffa MC, Berard M, Sugi T, McIntyre JA.
    J Rheumatol; 1996 Aug 01; 23(8):1375-9. PubMed ID: 8856616
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE).
    Bertolaccini ML, Murru V, Sciascia S, Sanna G, Khamashta MA.
    Thromb Res; 2012 Dec 01; 130(6):914-8. PubMed ID: 23079292
    [Abstract] [Full Text] [Related]

  • 19. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M, Boffa MC.
    Lupus; 2009 Sep 01; 18(10):920-3. PubMed ID: 19671793
    [Abstract] [Full Text] [Related]

  • 20. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V.
    Zammiti W, Mtiraoui N, Kallel C, Mercier E, Almawi WY, Mahjoub T.
    Reproduction; 2006 Apr 01; 131(4):817-22. PubMed ID: 16595732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.